Growth hormone: A wonder drug?;Hormone de croissance: Potion magique?

Revue de Medecine Interne

Volumn 19, Issue 4, 1998, Pages 279-285

  Schlienger, J L ^a   Goichot, B ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Adult GH deficiency; Cardiomyopathy; Denutrition; Growth hormone; Senescence

Indexed keywords

BINDING PROTEIN; GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ARTICLE; BODY COMPOSITION; DRUG ACTIVITY; GROWTH HORMONE DEFICIENCY; HEART DILATATION; HUMAN; MALNUTRITION; PHYSICAL ACTIVITY; SHORT STATURE; WELLBEING;

EID: 0032054638     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)89332-0     Document Type: Article

References (47)

1. Baumann G, Amburn K. Shaw MA. The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man. Endocrinology 1988 ; 122 : 976-84
2. Ernst M, Rodan GA, Increased activity of insulin-like growth factor (IG) in osteoblastic cells in the presence of growlh-horrnone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP3. Endocrinolog 1990 ; 127 : 807-14
3. Herman-Bovert VS, Prager D, Melmed S. Growth hormone. In: Melmed S, ed. The Pituitary. Oxford: Blackwell Science; 1995. p 98-135
4. Guler HP, Zapf J, Froesch. Short-term metabolic effects of recombinant human insulin-like growth factor 5 in healthy adults. N Engl J Med 1987 ; 217 : 137-40
5. Biglieri EG, Watlington CO, Forsham PH. Sodium retention with human growth hormone and its subfractions. J Clin Endocrinol Metab 1961 ; 21 : 361-70
6. Sacca L, Cittadini A. Fazio S. Growth hormone and the heart. Endocrinol Rev 1994 ; 15 : 555-73
7. Nagy E, Berczi I, Friesen HG. Regulation of immunity by lactogenic and growth hormones. Acta Endocrinol 1983 : 102 : 351-7
8. Weigent DA, Blalock JE. Growth hormone and the immune system. Prog Neuroendocrinol Immunol 1990 ; 3 : 231-41
9. De Boer H, Block GJ, Van der Been EA. Clinical aspect s of growth hormone deficiency in adults. Endocrinol Rev 1995 ; 16 : 63-86
10. Binnerts A, Swan GR, Wilson JHP, Hoogerbrugge N. Pols HAP, Birkenhager JL et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol 1992 ; 37 : 79-87
11. Salomon F, Cuneo RC, Hesp R, Sonksen PH. The effects of treatment with recombinent human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989 ; 321 : 1797-803
12. Rosen R, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990 ; 336 : 285-8
13. Hunter MK, Rosenfeld RG. Can we diagnose growth hormone deficiency? Curr Opin Endocrinol Diab 1996 ; 3 : 83-7
14. De Boer H, Blok GJ, Popp-Snijder C, Stuurman L, Baxter RC, Van der Veen E. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 1996 ; 81 : 1371-7
15. Mardh G, Lundin K, Borg G, Jonsson B, Lindberg A. Growth hormone replacement therapy in adult hypopituitary patients with growth hormone deficiency: combined data from 12 european placebo-controlled clinical trial. Endocrinol Metab 1994 : 1 Suppl A : 43-9
16. Weaver JU. Monson JP, Noonan K, John WG, Edwards A, Evans KA et al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insu lin sensitivity and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 1995 ; 80 : 153-9
17. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocrinol Rev 1993 ; 14 : 20-39
18. Jorgensen JO, Christiansen JS. Growth hormone therapy. Brave new senescence: GH in adults. Lancet 1993 ; 341 : 1247-8
19. Oscarsson J. Ottosson M, Wiklund O. Low dose continuously infused growth hormone results in increased lipoprutein A and decreased low density lipoprotein cholesterol concentrations in middle aged men. Clin Endocrinol 1994 ; 41 : 109-16
20. Holloway L, Butterfield G, Hintz R, Gesundheit N, Marcus R, Effects of recombinant human growth hormone or metabolic indices, body composition and bone turnover in healthy elderly women. J Clin Endocrinol Metab 1994 ; 49 : 470-9
21. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY. Goldberg AF et al. Effect of human growth hormone in men over 60 years old. N Engl J Med 1990 ; 323 : 1-6
22. Ward HC, Halliday D, Sim AJW. Protein and energy metabolism with biosynthetic human growth hormone alter gastrointestinal surgery. Ann Surg 1987 ; 206 : 56-61
23. Ponting GA, Halliday D, Teale JD, Sim JW. Postoperative positive nitrogen balance with intraveinous hyponutrition and growth hormone. Lancet 1988 ; i : 438-40
24. Vara-Thorbeck R, Guerrero JA, Rosell J, Ruiz-Requena E, Capitan JM. Exogenous growth hormone: effects on the catabolic response to surgically produced acute stress and on postoperative immune function. World J Surg 1993 ; 17 : 530-8
25. Voerman HJ, Strack Van Schijndel RJM, Groeneveld ABJ, De Boer H, Nauta JP, Van der Veen EA et al. Effects of recombinant human growth hormone in patients with severe sepsis. Ann Surg 1992 ; 216 : 648-55
26. Kotler DP, Thierney AR, Culpepper-Morgan JA, Wang J, Pierson Jr RN. Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. J Parenter Enteral Nutr 1990 ; 14 : 454-458
27. Bitsch T. Recombinant human growth hormone therapy in patients with wasting associated with human immunodeficiency virus infection. In: Ranke MB, eds. New directions in growth hormone therapy. Mannheim: J and J Verlag; 1995. p 74-80
28. Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992 ; 327 : 329-37
29. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Bodyweight in chronic obstructive pulmonary disease. The National Institutes of Health intermittent positive-pressure breathing trial. Am Rev Respir Dis 1989 ; 139 : 1435-8
30. Donahoe M, Rodgers RM. Nutritonal assessment and support in chronic obstructive pulmonary disease. Clin Chest Med 1990 ; 11 :487-504
31. Pape GS, Friedman M, Underwood LE, Clemrnons DR. The effect of growth hormone on weight gain and pulmonary func-tion in patients with chronic obstructive lung disease. Chest 1991 ; 99 : 1495-500
32. Burdet L, Schutz Y, de Muralt B, Pichard C, Fitting JW. Administration of recombinant growth hormone in undernourrished patients with chronic obstructive pulmonary disease. In: Ranke MB, Christiansen NJS, eds. The complexity of endocrine systems: interactions of growth hormone, insulin-like growth hormone and growth hormone-releasing peptides. Mannheim: J and J Verlag; 1996. p 170-9
33. Valcavi R, Gaddi O, Zini M, Iavicoli M, Mellino U, Portioli I. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment. J Clin Endocrinol Metab 1995 ; 80 : 659-66
34. Giustina A, Boni E, Romanelli O, Grassi V, Giustina G. Cardiopulmonary performance during exercise in acromegaly and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am J Cardiol 1995 ; 75 : 1042-7
35. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnston DG, Foale RA. Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J 1992 ; 67 : 92-6
36. Fazio S, Sabatini D, Capaldo B, Vigoritto C, Giordano A, Guida R et al. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 1996 ; 334 : 809-14
37. Bonjour JP, Chevalley T, Schurch MA, Rizzoli R. Hormone de croissance, IGF et métabolisme osseux de l'adulte. Ann Endocrinol (Paris) 1996 ; 57 : 147-9
38. Eriksen EF, Kassem M, Brixen K. Growth hormone and insu-lin-like growth factors as anabolic therapies for osteoporosis. Horm Res 1993 ; 40 : 95-8
39. Tkatch L, Rapin CH, Rizzoli R, Slosman D, Nydegger V, Vasey H et al. Benefits of oral protein supplement in elderly patients with fracture of the proximal femur. J Am Coll Nutr 1992 ; 11 : 519-25
40. Katz E, Ricciarelli E, Adashi EY. Review: the potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil Steril 1993 ; 59 : 8-34
41. Homburg R, Eshel A, Abdalla HI, Jacobs HS. Growth hormone facilitates ovulation induction by gonadotrophins. Clin Endocrinol 1988 ; 29 : 113-7
42. Owen EJ, West C, Mason BA. Co-treatment with growth hormone of sub-optimal responders in IVF-ET. Hum Reprod 1991 ; 6 : 524-8
43. Shoham Z, Homburg R, Owen EJ, Conway GS, Ostergaard H. Jacobs HS. The role of treatment with growth hormone in infertile patients. Baillieres Clin Obstet Gynaecol 1992 ; 6 : 267-81
44. Bennett RM, Clark SR, Campbell SM, Buckhard CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum 1992 ; 35 : 1113-6
45. Bennett RM, Clark SR, Burchardt CS, Walczyk J. A double blind placebo controled study of growth hormone therapy in fibromyalgia, J Muscul Skel Pain 1995 ; 3 Suppl 1 : 110
46. Haupt HA. Anabolic steroids and growth hormone. Am J Sports Med 1993 ; 21 : 468-74
47. Wadler GI. Drug use update. Med Clin North Am 1994 ; 78 : 439-55